Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/e67324c2-c809-4dbc-a9ea-a7f5b1125a84/

LUPIN

Lupin Limited
Chart
2,496.30 INR
Latest Week 2026-07-10
HealthcareDrug Manufacturers - Specialty & GenericMEGA
Snapshot 2026-07-12 · 0.6w · Fresh
0.94
OS Score
64.0%
Value
98.0%
Quality
86.0%
Momentum
7/9
F-Score
0.792
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
10 of 23 passing
★
OS Composite
OS 0.940
↗
Trending Value
✗
◆
Quality × Value
QV 0.792
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
Yes
▣
Piotroski Bargains
F7
🔬
Quality Compounders
✗
📈
Consistent Earners
Yes
🌱
GARP
Rev +24%
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 22%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
Vol 17%
🏷
Sector Cheapest
✗
🧠
Capital Allocators
CAQ 0.81
⚡
Risk-Adj Momentum
RAM 1.28
V
Value Analysis
Cheapness relative to fundamentals
64.0%ile
P/E
24.7×
P/S
4.4×
P/B
5.1×
E/P
0.0664
FCF Yield
0.045
EBITDA/EV
0.064
SH Yield
0.005
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
66.00000000
/100 — 1=cheapest
VC2 (Trending Value)
61.00000000
/100
VC3 (Buyback)
64.00000000
/100
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
98.0%ile
ROE
0.206
ROA
0.121
Net Margin
0.176
Op Margin
0.296
GPA
0.496
Current
1.90
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.239
Earn Growth
0.623
Stability
0.257
lower=better
Accruals
-0.071
lower=better
5yr Consist
Yes
ROE of 21% is exceptional.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
86.0%ile
6M Return
14.4%
12M Return
32.6%
12-1 Mom
21.8%
Risk-Adj
1.28
Vol 252d
17.0%
Vol 60d
30.8%
↑ Expanding
Max DD 12M
-6.6%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 22% is very strong — a clear uptrend. Near-term vol (31%) is expanding vs long-term (17%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.94
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 160 peers
Sector Value %ile
88.2%
Sector Quality %ile
98.1%
P/E z-score
-0.24
P/B z-score
-0.16
Sector Avg OS
41.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
LINCOLN Lincoln Pharmaceuticals Limited 97.0% 89.0% 80.0% 79.0%
VENUSREM Venus Remedies Limited 96.0% 68.0% 95.0% 99.0%
NATCOPHARM NATCO Pharma Limited 96.0% 86.0% 88.0% 68.0%
SPARC Sun Pharma Advanced Research Company Limited 96.0% 71.0% 91.0% 94.0%
STAR Strides Pharma Science Limited 95.0% 75.0% 91.0% 84.0%
AUROPHARMA Aurobindo Pharma Limited 95.0% 73.0% 83.0% 90.0%
SAGILITY Sagility Limited 93.0% 78.0% 87.0% 64.0%
AKUMS AKUMS DRUGS AND PHARMA L 88.0% 62.0% 79.0% 83.0%
Factor Interactions
Volatility Expanding
60-day vol (31%) significantly exceeds 252-day (17%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
43.9% avg (7 factors)
Quality
A
76.7% avg (7 factors)
Momentum
B
61.1% avg (4 factors)
Risk
A
88.3% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends6 snapshots
Factor Persistence6 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.940—6—
Value %ile0.640—0—
Quality %ile0.980—6—
Momentum %ile0.860—6—
F-Score7.000—6—
Confidence0.920—6—
Volatility0.170—6—
Value Lens2021-07-13 → 2026-07-12
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
24.67
Earnings Yield (E/P)
0.0664
Price / Sales
4.35
Price / Book
5.08
Price / Cash Flow
15.56
FCF Yield
4.5%
EBITDA / EV
6.4%
Sales Yield (1/P·S)
0.2248
Shareholder Yield
Div + net buyback / mktcap
0.5%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
20.6%
Return on Assets
12.1%
Net Margin
17.6%
Operating Margin
29.6%
Gross Profit / Assets
Novy-Marx GPA
49.6%
Current Ratio
1.90
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.071
External Financing
Net issuance — lower=better
0.002
MomentumPrice trend strength over different horizons
6M Return
14.4%
12M Return
32.6%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
21.8%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.28
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
23.9%
Earnings Growth (YoY)
62.3%
Earnings Stability (CV)
Lower = more stable
0.257
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
7
Dividend Yield
0.5%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
66
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
61
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
64
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
Yes
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity